Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Paxlovid is the most commonly prescribed at home treatment for COVID-19 in the U.S. It is approved to treat COVID in adults who are at risk of severe complications from the illness.

Study: The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19. Image Credit: Tobias Arhelger/Shutterstock.com Background ...

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19. In December 2021, the FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric ...

Tens of thousands of Americans are hospitalized with COVID-19 every week. Thousands die from it every month. And yet, an antiviral treatment proven to lessen the chances of severe outcomes is ...

People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.

FDA researchers estimated, based on Covid rates in January, that Paxlovid could "lead to 1,500 lives saved and 13,000 hospitalizations averted each week" in the U.S.

When Paxlovid was first authorized for emergency use in the U.S. in December 2021, it was free for anyone who needed it. Once the government stopped funding the treatment, Pfizer set a list price ...